Skip to main content
. 2021 Apr 23;9:583197. doi: 10.3389/fped.2021.583197

Table 3.

Lymph-nodal characteristics after contrast administration.

Characteristics of adenopathies Tot (37) <5 (23) ≥ 5 (14) Confirmed TB (30) Probable TB (7) P
Ring 6 (16.2) 4 (17.3) 2 (14.3) 4 (13.3) 2 (28.6) Ns
Non-homogeneous 1 (2.7) - 1 (7.1) 1 (3.3) - Ns
Homogeneous 15 (40.5) 10 (43.5) 5 (35.7) 11 (36.7) 4 (57.1) Ns
Calcifications 10 (27) 5 (21.7) 5 (35.7) 7 (23.3) 3 (42.9) Ns
Pointed 4 (10.8) 2 (8.7) 2 (14.3) 3 (10) 1 (14.3) Ns
Shell 5 (13.5) 3 (13.4) 2 (14.3) 3 (10) 2 (28.6) Ns
Moriform 1 (2.7) - 1 (7.1) 1 (3.3) - Ns
Size Ns
<1 cm 9 (24.3) 6 (26.1) 3 (21.4) 7 (23.3) 2 (28.6) Ns
1-2 18 (48.6) 12 (52.2) 6 (42.8) 16 (53.3) 2 (28.6)
>2 cm 6 (16.2) 3 (13.0) 3 (21.4) 4 (13.3) 2 (28.6)
NO linf 4 (10.8) 2 (8.7) 2 (14.3) 3 (10) 1 (14.3)
Lymphnode as only pathological finding 4 (10.8) 4 (17.3) - 2 (6.67) 2 (28.6) Ns

NS, Not significant.